Outset Medical, Inc. (OM)
NASDAQ: OM · Real-Time Price · USD
0.726
-0.025 (-3.32%)
At close: Nov 20, 2024, 4:00 PM
0.704
-0.022 (-3.00%)
Pre-market: Nov 21, 2024, 7:24 AM EST
Outset Medical Stock Forecast
OM's stock price has decreased by -85.94% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Outset Medical stock have an average target of 4.38, with a low estimate of 3.00 and a high estimate of 6.00. The average target predicts an increase of 503.56% from the current stock price of 0.73.
Analyst Consensus: Buy
* Price targets were last updated on Aug 8, 2024.
Analyst Ratings
The average analyst rating for Outset Medical stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 3 | 3 | 3 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy → Hold Downgrades $6 → $3 | Buy → Hold | Downgrades | $6 → $3 | +313.39% | Aug 8, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $9 → $3 | Strong Buy | Maintains | $9 → $3 | +313.39% | Aug 8, 2024 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $5 → $6 | Hold → Buy | Upgrades | $5 → $6 | +726.79% | Jun 21, 2024 |
| BTIG | BTIG | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +726.79% | Apr 8, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $14 → $6 | Buy → Hold | Downgrades | $14 → $6 | +726.79% | Jan 12, 2024 |
Financial Forecast
Revenue This Year
114.93M
from 130.38M
Decreased by -11.85%
Revenue Next Year
128.50M
from 114.93M
Increased by 11.81%
EPS This Year
-1.91
from -3.48
EPS Next Year
-1.36
from -1.91
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 118.0M | 135.7M | 224.0M | ||
| Avg | 114.9M | 128.5M | 160.2M | ||
| Low | 107.8M | 116.6M | 131.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -9.5% | 18.0% | 74.3% | ||
| Avg | -11.8% | 11.8% | 24.7% | ||
| Low | -17.3% | 1.5% | 2.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.89 | -1.31 | -1.02 | ||
| Avg | -1.91 | -1.36 | -1.17 | ||
| Low | -1.83 | -1.42 | -1.32 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.